Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
AbbVie
Scientific Title
A Phase 1 Dose Escalation and Phase 2 Randomized Double-Blind Study of Veliparib in Combination With Carboplatin and Etoposide as a Therapy of Treatment-Naive Extensive Stage Disease Small Cell Lung Cancer